Human Infection Studies for Vaccine Development (Closed)
This scheme supports teams of researchers working on human infection studies in low- and middle-income countries. The aim is to accelerate vaccine development.
Scheme at a glance
This scheme is now closed
- Lead applicant career stage:
- Administering organisation location:
- Funding amount:
£3 million to £5 million
- Funding duration:
Up to 5 years